VIDEO: Major Bleeding in Patients with Atrial Fibrillation and Diabetes Taking Rivaroxaban
W. Frank Peacock, IV, MD, discusses the risk of major bleeding among patients with atrial fibrillation and diabetes who are receiving rivaroxaban.
Diabetes
Incretin-Based Drugs Not Associated With Increased Risk of Heart Failure Hospitlization
Researchers examined heart failure risk of nearly 1.5 million patients in Canada, the United States, and the United Kingdom and found no increased risk for hospitalization with incretin-based drugs vs oral antidiabetic-drug combinations.
Disease Management Program Did Not Reduce Racial and Ethnic Disparities in Diabetes Care
A 3-year telephone-based disease management program did not reduce racial and ethnic disparities in diabetes care.
Gilbenclamide and Thiazolidinedione Prescriptions Decreased, Gliclazide and DPP-4 Inhibitors Increased
Trends in antihyperglycemic treatment reveal a decrease in glibenclamide and thiazolidinedione and an increase in gliclazide and dipeptidyl peptidase-4 inhibitors.
Study Suggests Doctors Miss Opportunities to Treat Prediabetes
Of patients who had doctor-ordered blood tests, 33.6% had glycated hemoglobin levels that indicated prediabetes but very few were told of their condition and only 23% began treatment.
Short-Term Air Pollutant Exposure Linked to Poor Metabolic Outcomes
Researchers noted a correlation for annual average particulate matter with higher fasting glucose, homeostasis model assessment of insulin resistance, and low-lipoprotein density cholesterol.
Intensive Diabetes Therapy Reduces Risk of Cardiovascular Disease
Diabetes Control and Complications Trial reports that patients who were taught intensive therapy for type 1 diabetes experienced clinically beneficial effects on cardiovascular outcomes at 30 years.
Renin Inhibitor Aliskiren May Not Significantly Reduce Albuminuria in Type 2 Diabetes
Renin inhibitor aliskiren may not reduce albuminuria levels enough for cardiovascular and renal risk protection.
Vitamin D: No Effect on Beta-Cell Function, Insulin Sensitivity, or Glycemic Control
Vitamin D treatment had no effect on first- or second-phase insulin secretion compared with placebo.
Fasting Glycemia Screening vs Glucose Tolerance Test for Gestational Diabetes
Fasting glycemia screening for gestational diabetes had a sensitivity of 78.5%, which would allow for glucose loading to be avoided in 63.8% of women.
- Loading...
Loading...
Loading... 
Loading...